Honore, A., Moen, C. A., Reisæter, L. A. R., Gravdal, K., Juliebø-Jones, P., & Beisland, C. (2026). Transition to targeted transperineal prostate biopsies does not impact progression to curative treatment for patients initially entered into active surveillance. Urologia Journal, 93(2), 185. https://doi.org/10.1177/03915603251395510
Chicago Style (17th ed.) CitationHonore, Alfred, Christian Arvei Moen, Lars Anders Rokne Reisæter, Karsten Gravdal, Patrick Juliebø-Jones, and Christian Beisland. "Transition to Targeted Transperineal Prostate Biopsies Does Not Impact Progression to Curative Treatment for Patients Initially Entered into Active Surveillance." Urologia Journal 93, no. 2 (2026): 185. https://doi.org/10.1177/03915603251395510.
MLA (9th ed.) CitationHonore, Alfred, et al. "Transition to Targeted Transperineal Prostate Biopsies Does Not Impact Progression to Curative Treatment for Patients Initially Entered into Active Surveillance." Urologia Journal, vol. 93, no. 2, 2026, p. 185, https://doi.org/10.1177/03915603251395510.